Lage MJ - Search Results

1

The medical costs of migraine and comorbid anxiety and depression.

Pesa J, Lage MJ. Pesa J, et al. Among authors: lage mj. Headache. 2004 Jun;44(6):562-70. doi: 10.1111/j.1526-4610.2004.446004.x. Headache. 2004. PMID: 15186300

2

Medical and productivity costs of anxiety disorders: case control study.

Marciniak M, Lage MJ, Landbloom RP, Dunayevich E, Bowman L. Marciniak M, et al. Among authors: lage mj. Depress Anxiety. 2004;19(2):112-20. doi: 10.1002/da.10131. Depress Anxiety. 2004. PMID: 15022146

3

Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder.

Secnik K, Swensen A, Lage MJ. Secnik K, et al. Among authors: lage mj. Pharmacoeconomics. 2005;23(1):93-102. doi: 10.2165/00019053-200523010-00008. Pharmacoeconomics. 2005. PMID: 15693731

4

The cost of treating anxiety: the medical and demographic correlates that impact total medical costs.

Marciniak MD, Lage MJ, Dunayevich E, Russell JM, Bowman L, Landbloom RP, Levine LR. Marciniak MD, et al. Among authors: lage mj. Depress Anxiety. 2005;21(4):178-84. doi: 10.1002/da.20074. Depress Anxiety. 2005. PMID: 16075454

5

The association between diabetes related medical costs and glycemic control: a retrospective analysis.

Oglesby AK, Secnik K, Barron J, Al-Zakwani I, Lage MJ. Oglesby AK, et al. Among authors: lage mj. Cost Eff Resour Alloc. 2006 Jan 16;4:1. doi: 10.1186/1478-7547-4-1. Cost Eff Resour Alloc. 2006. PMID: 16412255 Free PMC article.

6

The cost of treating skeletal-related events in patients with prostate cancer.

Lage MJ, Barber BL, Harrison DJ, Jun S. Lage MJ, et al. Am J Manag Care. 2008 May;14(5):317-22. Am J Manag Care. 2008. PMID: 18471035

7

Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge.

Hassan M, Lage MJ. Hassan M, et al. Among authors: lage mj. Am J Health Syst Pharm. 2009 Feb 15;66(4):358-65. doi: 10.2146/ajhp080374. Am J Health Syst Pharm. 2009. PMID: 19202045

8

Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy.

Lage MJ, Fabunmi R, Boye KS, Misurski DA. Lage MJ, et al. Adv Ther. 2009 Feb;26(2):217-29. doi: 10.1007/s12325-009-0002-0. Epub 2009 Feb 14. Adv Ther. 2009. PMID: 19219409

9

Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate.

Lage MJ, Gross GN, Brewster C, Spalitto A. Lage MJ, et al. Adv Ther. 2009 Aug;26(8):762-75. doi: 10.1007/s12325-009-0056-z. Epub 2009 Aug 8. Adv Ther. 2009. PMID: 19669630

10

The relationship between alternative medication possession ratio thresholds and outcomes: evidence from the use of glatiramer acetate.

Oleen-Burkey MA, Dor A, Castelli-Haley J, Lage MJ. Oleen-Burkey MA, et al. Among authors: lage mj. J Med Econ. 2011;14(6):739-47. doi: 10.3111/13696998.2011.618517. Epub 2011 Sep 13. J Med Econ. 2011. PMID: 21913796

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results